消除麻疹进展——东南亚区域,2003—2020年
世界卫生组织东南亚区域会员国于2013年设定2020年消除麻疹目标,2019年修订为2023年消除麻疹和风疹。
要点
- 2013年设定2020年消除麻疹目标,2019年修订为2023年消除麻疹和风疹。
- 2003—2020年所有国家引入MCV2,MCV1覆盖率从65%升至88%,MCV2从6%升至80%。
核心结论
- 要实现区域2023年消除麻疹,急需加强常规免疫服务、提高MCV覆盖率、开展定期高质量补充免疫活动并加强麻疹病例监测和实验室能力。
研究设计与样本
- 本报告更新既往报告,描述2003—2020年世界卫生组织东南亚区域消除麻疹的进展。
主要发现
- 2002年MCV1常规免疫覆盖率为70%,仅三个东南亚区域国家在常规免疫中增加MCV2。
- 2003—2020年所有国家引入MCV2,估计MCV1覆盖率从65%升至88%(上升35%),MCV2覆盖率从6%升至80%(上升1,233%)。
- 到2020年五个国家验证达到消除麻疹。
关键数值与推荐
- 推荐策略包括:每个地区通过常规或补充免疫活动达到并维持≥95%的两剂麻疹和风疹含疫苗覆盖率。
- 推荐策略包括:建立并维持敏感及时的病例监测系统,符合推荐性能指标。
- 推荐策略包括:建立并维持认证实验室网络。
- 推荐策略包括:及时识别、调查和响应麻疹暴发。
- 推荐策略包括:与其他公共卫生倡议合作实现上述四项策略。
临床怎么用
- 原文未据此给出针对个体临床实践的推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In 2013, member states of the World Health Organization (WHO) South-East Asia Region* (SEAR) adopted the goal of measles elimination and rubella and congenital rubella syndrome control† by 2020 (1). In 2014, to provide impetus toward achieving this goal, the Regional Director declared measles elimination and rubella control one of the Regional Flagship Priorities. In 2019, SEAR member states declared a revised goal of eliminating both measles and rubella§ by 2023 (2). The recommended strategies to achieve elimination include 1) achieving and maintaining ≥95% coverage with 2 doses of measles- and rubella-containing vaccine in every district through routine or supplementary immunization activities¶ (SIAs); 2) developing and sustaining a sensitive and timely case-based surveillance system that meets recommended performance indicators**; 3) developing and maintaining an accredited laboratory network; 4) achieving timely identification, investigation, and response to measles outbreaks; and 5) collaborating with other public health initiatives to achieve the preceding four strategies. This report updates a previous report and describes progress toward measles elimination in SEAR during 2003-2020 (3). In 2002, coverage with the first dose of a measles-containing vaccine in routine immunization (MCV1) was 70%, and only three countries in SEAR had added a second routine dose of measles-containing vaccine in routine immunization (MCV2). During 2003-2020, all countries introduced MCV2, and estimated coverage with MCV1 increased 35%, from 65% to 88%, and coverage with MCV2 increased 1,233% from 6% to 80%. Approximately 938 million persons were vaccinated in SIAs. Annual reported measles incidence declined by 92%, from 57.0 to 4.8 cases per 1 million population, and estimated deaths decreased by 97%; an estimated 9.3 million deaths were averted by measles vaccination. By 2020, five countries were verified as having achieved measles elimination. To achieve measles elimination in the region by 2023, additional efforts are urgently needed to strengthen routine immunization services and improve measles-containing vaccine (MCV) coverage, conduct periodic high-quality SIAs, and strengthen measles case-based surveillance and laboratory capacity.
引用
- Khanal S, Kassem AM, Bahl S, et al. Progress Toward Measles Elimination - South-East Asia Region, 2003-2020. MMWR Morb Mortal Wkly Rep. 2022. PMID: 35980874. doi:10.15585/mmwr.mm7133a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。